Search research articles
Contact Us
Filters
Showing results (271-280 of 418) with videos related to
Page
of 42
Sort By:
International Journal of Cancer
|
April 1, 2005
Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin
Yongyin Wang, Dayuan Gao, David P Atencio, et al.
Dermatology and Therapy
|
February 27, 2021
Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists
Bruce Strober, Nirali Kotowsky, Rose Medeiros, et al.
Drugs - Real World Outcomes
|
June 24, 2024
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry
Mark Lebwohl, Bruce Strober, Amy Schrader, et al.
Dermatology and Therapy
|
February 22, 2026
Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study
Christopher G Bunick, Ruth Ann Vleugels, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology
|
April 14, 2018
Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis
Claus Zachariae, Kenneth Gordon, Alexandra B Kimball, et al.
Journal of Drugs in Dermatology : JDD
|
May 6, 2025
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
Journal of the American Academy of Dermatology
|
April 17, 2018
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)
Mark Lebwohl, Andrew Blauvelt, Carle Paul, et al.
Free Radical Biology & Medicine
|
October 11, 2005
Benzo[a]pyrene and its metabolites combined with ultraviolet A synergistically induce 8-hydroxy-2'-deoxyguanosine via reactive oxygen species
Dayuan Gao, Yunjing Luo, Denise Guevara, et al.
Journal of the American Academy of Dermatology
|
October 4, 2005
Oral phosphate binders in the treatment of pseudoxanthoma elasticum
Daniel W Sherer, Giselle Singer, Jaime Uribarri, et al.
Archives of Dermatological Research
|
April 29, 2025
Systemic Janus kinase inhibitors in the management of granuloma annulare
Scott Stratman, Shivkar Amara, Kathryn Jayne Tan, et al.
Page
of 42
Search research articles
Search
Showing results (271-280 of 418) with videos related to
Sort By:
Page
of 42
International Journal of Cancer
|
April 1, 2005
Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin
Yongyin Wang, Dayuan Gao, David P Atencio, et al.
Dermatology and Therapy
|
February 27, 2021
Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists
Bruce Strober, Nirali Kotowsky, Rose Medeiros, et al.
Drugs - Real World Outcomes
|
June 24, 2024
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry
Mark Lebwohl, Bruce Strober, Amy Schrader, et al.
Dermatology and Therapy
|
February 22, 2026
Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study
Christopher G Bunick, Ruth Ann Vleugels, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology
|
April 14, 2018
Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis
Claus Zachariae, Kenneth Gordon, Alexandra B Kimball, et al.
Journal of Drugs in Dermatology : JDD
|
May 6, 2025
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
Journal of the American Academy of Dermatology
|
April 17, 2018
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)
Mark Lebwohl, Andrew Blauvelt, Carle Paul, et al.
Free Radical Biology & Medicine
|
October 11, 2005
Benzo[a]pyrene and its metabolites combined with ultraviolet A synergistically induce 8-hydroxy-2'-deoxyguanosine via reactive oxygen species
Dayuan Gao, Yunjing Luo, Denise Guevara, et al.
Journal of the American Academy of Dermatology
|
October 4, 2005
Oral phosphate binders in the treatment of pseudoxanthoma elasticum
Daniel W Sherer, Giselle Singer, Jaime Uribarri, et al.
Archives of Dermatological Research
|
April 29, 2025
Systemic Janus kinase inhibitors in the management of granuloma annulare
Scott Stratman, Shivkar Amara, Kathryn Jayne Tan, et al.
Page
of 42